Tag: Health Care

Displaying 141 - 160 of 1394 results.

Pages

Federal Trade Commission Chairman Joseph J. Simons today joined Food and Drug Administration Commissioner Stephen Hahn in signing a joint statement promoting competition in biologics markets.
The Federal Trade Commission has closed its investigation into the proposed merger of Aveanna Healthcare and Maxim Healthcare.
The Federal Trade Commission has filed a complaint in federal district court against Vyera Pharmaceuticals, LLC, alleging an elaborate anticompetitive scheme to preserve a monopoly for the life-saving drug, Daraprim. The Commission vote to issue the complaint was 5-0. The complaint...
The Federal Trade Commission has filed a complaint in federal court against Vyera Pharmaceuticals, LLC, alleging an elaborate anticompetitive scheme to preserve a monopoly for the life-saving drug, Daraprim.
The Federal Trade Commission has issued an administrative complaint and authorized a federal court action to block the proposed merger of Jefferson Health and Albert Einstein Healthcare Network, two leading providers of inpatient general acute care hospital services and inpatient...
Federal Trade Commission staff submitted comments to two state legislatures on the impact of legislative proposals to modify the supervision requirements imposed on advanced practice registered nurses, or APRNs.
FTC staff comment concerning Kansas House Bill 2412, a proposal to expand the scope of practice for Advanced Practice Registered Nurses (APRNs) in Kansas. 
Comment by FTC staff concerning Ohio House Bill 177, a proposal to expand the scope of practice of Advanced Practice Registered Nurses (APRNs) in Ohio. 
Following today’s announcement that the parties are abandoning their proposed merger, Gail Levine, Deputy Director of the Bureau of Competition, made this statement:“This deal threatened to let a monopolist extinguish nascent competition in a growing health care market: next-generation DNA...
The Federal Trade Commission has authorized an action to block Illumina Inc.’s proposed $1.2 billion acquisition of Pacific Biosciences of California (PacBio). The Commission alleges in an administrative complaint that Illumina is seeking to unlawfully maintain its monopoly in the U.S. market for...
The Federal Trade Commission has closed its investigation into Roche Holding AG’s proposed acquisition of Spark Therapeutics, Inc.
The Federal Trade Commission staff has submitted a comment to the Texas Medical Board raising concerns that the board’s Proposed Rule § 193.13 could harm competition by impeding access to surgical and other health care services that require anesthesia or related services.

Pages